342 related articles for article (PubMed ID: 35973687)
1. Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields]).
Shams S; Patel CB
J Mol Cell Biol; 2022 Dec; 14(8):. PubMed ID: 35973687
[TBL] [Abstract][Full Text] [Related]
2. Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy.
Pohling C; Nguyen H; Chang E; Schubert KE; Nie Y; Bashkirov V; Yamamoto V; Zeng Y; Stupp R; Schulte RW; Patel CB
Bioelectrochemistry; 2023 Feb; 149():108287. PubMed ID: 36306728
[TBL] [Abstract][Full Text] [Related]
3. An overview of potential novel mechanisms of action underlying Tumor Treating Fields-induced cancer cell death and their clinical implications.
Karanam NK; Story MD
Int J Radiat Biol; 2021; 97(8):1044-1054. PubMed ID: 33086019
[TBL] [Abstract][Full Text] [Related]
4. Tumor treating fields: a new frontier in cancer therapy.
Davies AM; Weinberg U; Palti Y
Ann N Y Acad Sci; 2013 Jul; 1291():86-95. PubMed ID: 23659608
[TBL] [Abstract][Full Text] [Related]
5. Integration of Tumor-Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies.
Wang Y; Pandey M; Ballo MT
Oncologist; 2019 Dec; 24(12):e1426-e1436. PubMed ID: 31444292
[TBL] [Abstract][Full Text] [Related]
6. A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling.
Wenger C; Miranda PC; Salvador R; Thielscher A; Bomzon Z; Giladi M; Mrugala MM; Korshoej AR
IEEE Rev Biomed Eng; 2018; 11():195-207. PubMed ID: 29993870
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of tumor treating fields for malignant brain tumors.
Zhou Y; Xing X; Zhou J; Jiang H; Cen P; Jin C; Zhong Y; Zhou R; Wang J; Tian M; Zhang H
Cancer Rep (Hoboken); 2023 May; 6(5):e1813. PubMed ID: 36987739
[TBL] [Abstract][Full Text] [Related]
8. Permeabilizing Cell Membranes with Electric Fields.
Aguilar AA; Ho MC; Chang E; Carlson KW; Natarajan A; Marciano T; Bomzon Z; Patel CB
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34068775
[TBL] [Abstract][Full Text] [Related]
9. Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy.
Jo Y; Kim EH; Sai S; Kim JS; Cho JM; Kim H; Baek JH; Kim JY; Hwang SG; Yoon M
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30469352
[TBL] [Abstract][Full Text] [Related]
10. Tumour treating fields therapy for glioblastoma: current advances and future directions.
Rominiyi O; Vanderlinden A; Clenton SJ; Bridgewater C; Al-Tamimi Y; Collis SJ
Br J Cancer; 2021 Feb; 124(4):697-709. PubMed ID: 33144698
[TBL] [Abstract][Full Text] [Related]
11. Tumor Treating Fields Technology: Alternating Electric Field Therapy for the Treatment of Solid Tumors.
Benson L
Semin Oncol Nurs; 2018 May; 34(2):137-150. PubMed ID: 29631935
[TBL] [Abstract][Full Text] [Related]
12. Exploring the efficacy of tumor electric field therapy against glioblastoma: An in vivo and in vitro study.
Wu H; Yang L; Liu H; Zhou D; Chen D; Zheng X; Yang H; Li C; Chang J; Wu A; Wang Z; Ren N; Lv S; Liu Y; Jia M; Lu J; Liu H; Sun G; Liu Z; Liu J; Chen L
CNS Neurosci Ther; 2021 Dec; 27(12):1587-1604. PubMed ID: 34710276
[TBL] [Abstract][Full Text] [Related]
13. The Mechanisms of Action of Tumor Treating Fields.
Moser JC; Salvador E; Deniz K; Swanson K; Tuszynski J; Carlson KW; Karanam NK; Patel CB; Story M; Lou E; Hagemann C
Cancer Res; 2022 Oct; 82(20):3650-3658. PubMed ID: 35839284
[TBL] [Abstract][Full Text] [Related]
14. Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: Results of the PANOVA phase 2 study.
Rivera F; Benavides M; Gallego J; Guillen-Ponce C; Lopez-Martin J; Küng M
Pancreatology; 2019 Jan; 19(1):64-72. PubMed ID: 30396819
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma.
Riley MM; San P; Lok E; Swanson KD; Wong ET
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058901
[TBL] [Abstract][Full Text] [Related]
16. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
Stupp R; Taillibert S; Kanner A; Read W; Steinberg D; Lhermitte B; Toms S; Idbaih A; Ahluwalia MS; Fink K; Di Meco F; Lieberman F; Zhu JJ; Stragliotto G; Tran D; Brem S; Hottinger A; Kirson ED; Lavy-Shahaf G; Weinberg U; Kim CY; Paek SH; Nicholas G; Bruna J; Hirte H; Weller M; Palti Y; Hegi ME; Ram Z
JAMA; 2017 Dec; 318(23):2306-2316. PubMed ID: 29260225
[TBL] [Abstract][Full Text] [Related]
17. The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes.
Rehman AA; Elmore KB; Mattei TA
Neurosurg Focus; 2015 Mar; 38(3):E14. PubMed ID: 25727223
[TBL] [Abstract][Full Text] [Related]
18. Theory and application of TTFields in newly diagnosed glioblastoma.
Yu A; Zeng J; Yu J; Cao S; Li A
CNS Neurosci Ther; 2024 Mar; 30(3):e14563. PubMed ID: 38481068
[TBL] [Abstract][Full Text] [Related]
19. Tumor treating fields: a comprehensive overview of the underlying molecular mechanism.
Hong P; Kudulaiti N; Wu S; Nie J; Zhuang D
Expert Rev Mol Diagn; 2022 Jan; 22(1):19-28. PubMed ID: 34883030
[TBL] [Abstract][Full Text] [Related]
20. [Tumor treating fields in cancer treatment in Denmark].
Korshøj AR; Lukacova S; Mikic N; Cortnum SOS; Lassen-Ramshad Y; Guldberg TL; Severinsen KE; Thielscher A; Poulsen FR; Sørensen JCH; Oettingen GBV
Ugeskr Laeger; 2019 Oct; 181(20A):. PubMed ID: 31610842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
